The Future of "Minimally Invasive Neurosurgery"
In: Minimally invasive neurosurgery, Band 52, Heft 2, S. 61-61
ISSN: 1439-2291
11 Ergebnisse
Sortierung:
In: Minimally invasive neurosurgery, Band 52, Heft 2, S. 61-61
ISSN: 1439-2291
In: Minimally invasive neurosurgery, Band 42, Heft 1, S. 27-31
ISSN: 1439-2291
In: Minimally invasive neurosurgery, Band 52, Heft 1, S. 1-4
ISSN: 1439-2291
In: Minimally invasive neurosurgery, Band 52, Heft 3, S. 126-131
ISSN: 1439-2291
In: Minimally invasive neurosurgery, Band 43, Heft 4, S. 187-189
ISSN: 1439-2291
In: Minimally invasive neurosurgery, Band 46, Heft 1, S. 16-21
ISSN: 1439-2291
In: Minimally invasive neurosurgery, Band 45, Heft 3, S. 158-163
ISSN: 1439-2291
In: Minimally invasive neurosurgery, Band 42, Heft 4, S. 187-193
ISSN: 1439-2291
In: Minimally invasive neurosurgery, Band 52, Heft 4, S. 163-169
ISSN: 1439-2291
In: Minimally invasive neurosurgery, Band 45, Heft 1, S. 11-15
ISSN: 1439-2291
Validated in vitro methods for skin corrosion and irritation were adopted by the OECD and by the European Union during the last decade. In the EU, Switzerland and countries adopting the EU legislation, these assays may allow the full replacement of animal testing for identifying and classifying compounds as skin corrosives, skin irritants, and non irritants. In order to develop harmonised recommendations on the use of in vitro data for regulatory assessment purposes within the European framework, a workshop was organized by the Swiss Federal Office of Public Health together with ECVAM and the BfR. It comprised stakeholders from various European countries involved in the process from in vitro testing to the regulatory assessment of in vitro data. Discussions addressed the following questions: (1) the information requirements considered useful for regulatory assessment; (2) the applicability of in vitro skin corrosion data to assign the corrosive subcategories as implemented by the EU Classification, Labelling and Packaging Regulation; (3) the applicability of testing strategies for determining skin corrosion and irritation hazards; and (4) the applicability of the adopted in vitro assays to test mixtures, preparations and dilutions. Overall, a number of agreements and recommendations were achieved in order to clarify and facilitate the assessment and use of in vitro data from regulatory accepted methods, and ultimately help regulators and scientists facing with the new in vitro approaches to evaluate skin irritation and corrosion hazards and risks without animal data. -® 2011 Elsevier Inc.
BASE